Accurso F J, Wilkening R B
Department of Pediatrics, University of Colorado School of Medicine, Denver 80262.
Proc Soc Exp Biol Med. 1988 Jan;187(1):89-98. doi: 10.3181/00379727-187-42642.
To determine the temporal response of the fetal pulmonary circulation to pharmacologic vasodilators and to assess vasoreactivity following vasodilation, we infused either acetylcholine, histamine, or bradykinin directly into the left pulmonary artery of 21 chronically prepared fetal sheep. Blood flow (Q) to the left lung was measured by electromagnetic flow transducer. Left pulmonary artery infusion of acetylcholine at 1.5 micrograms.min-1 for 2 hr produced an increase in Q from 59 +/- 8 ml.min-1 to a peak of 113 +/- 10 ml.min-1 at 20 min into the infusion (P less than 0.001). After the peak at 20 min, Q steadily declined toward baseline to 66 +/- 7 ml.min-1 at the end of the 2-hr infusion period (P less than 0.01). Q in the 1/2-hr period following infusion was significantly less than the baseline period (47 +/- 6; P less than 0.04) with no change in pulmonary artery pressure. Similar patterns were seen with 2-hr infusions of histamine (150 ng.min-1) and bradykinin (100 ng.min-1). After a 2-hr infusion of one of the agents, a repeat infusion with that agent or a different one resulted in a diminished response. We conclude that fetal pulmonary vasodilation in response to local infusion of acetylcholine, histamine, or bradykinin is not sustained over a 2-hr period, and that following 2-hr exposure to vasodilators, pulmonary vascular resistance is increased and pulmonary vasoreactivity to pharmacologic vasodilators is decreased.
为了确定胎儿肺循环对药物性血管扩张剂的即时反应,并评估血管扩张后的血管反应性,我们将乙酰胆碱、组胺或缓激肽直接注入21只长期制备的胎羊的左肺动脉。通过电磁流量传感器测量左肺的血流量(Q)。以1.5微克·分钟⁻¹的速度向左肺动脉注入乙酰胆碱2小时,使血流量从59±8毫升·分钟⁻¹增加到注入后20分钟时的峰值113±10毫升·分钟⁻¹(P<0.001)。在20分钟达到峰值后,血流量在2小时注入期结束时稳步下降至基线水平,即66±7毫升·分钟⁻¹(P<0.01)。注入后半小时内的血流量显著低于基线期(47±6;P<0.04),肺动脉压力无变化。组胺(150纳克·分钟⁻¹)和缓激肽(100纳克·分钟⁻¹)注入2小时也观察到类似模式。在注入其中一种药物2小时后,重复注入同一种药物或另一种药物会导致反应减弱。我们得出结论,胎儿肺对局部注入乙酰胆碱、组胺或缓激肽的血管扩张反应在2小时内不能持续,并且在接触血管扩张剂2小时后,肺血管阻力增加,对药物性血管扩张剂的肺血管反应性降低。